Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prasugrel in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients

NCT04445623 is registered in ClinicalTrials.gov with Azienda Ospedaliera Universitaria Integrata Verona as lead sponsor.

NCT NCT04445623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04445623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prasugrel in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients
Lead sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2020
Completion date
January 31, 2021
Enrollment
128 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, thrombosis